These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38518387)

  • 1. Metformin's role in lowering colorectal cancer risk among individuals with diabetes from the Southern Community Cohort Study.
    Lawler T; Walts ZL; Giurini L; Steinwandel M; Lipworth L; Murff HJ; Zheng W; Warren Andersen S
    Cancer Epidemiol; 2024 Jun; 90():102566. PubMed ID: 38518387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of diabetes and mortality among colorectal cancer patients from the Southern Community Cohort Study.
    Lawler T; Hibler E; Walts ZL; Giurini L; Steinwandel M; Lipworth L; Murff HJ; Zheng W; Warren Andersen S
    Br J Cancer; 2024 Oct; 131(6):1050-1059. PubMed ID: 39030444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals.
    Lee MS; Hsu CC; Wahlqvist ML; Tsai HN; Chang YH; Huang YC
    BMC Cancer; 2011 Jan; 11():20. PubMed ID: 21241523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin usage and the risk of colorectal cancer: a national cohort study.
    Lee JW; Choi EA; Kim YS; Kim Y; You HS; Han YE; Kim HS; Bae YJ; Kim J; Kang HT
    Int J Colorectal Dis; 2021 Feb; 36(2):303-310. PubMed ID: 32968891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose aspirin does not lower the risk of colorectal cancer in patients with type 2 diabetes taking metformin.
    Shami JJP; Yan VKC; Wei Y; Alwafi H; Blais JE; Wan E; Wong CKH; Cheung KS; Leung WK; Wong MCS; Wong ICK; Chan EW
    J Intern Med; 2023 Mar; 293(3):371-383. PubMed ID: 36382924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
    Chen CH; Lin CL; Hsu CY; Kao CH
    QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes, metformin use, and colorectal cancer survival in postmenopausal women.
    Cossor FI; Adams-Campbell LL; Chlebowski RT; Gunter MJ; Johnson K; Martell RE; McTiernan A; Simon MS; Rohan T; Wallace RB; Paulus JK
    Cancer Epidemiol; 2013 Oct; 37(5):742-9. PubMed ID: 23773299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
    Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
    JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin use is not associated with colorectal cancer incidence in type-2 diabetes patients: evidence from methods that avoid immortal time bias.
    Zhang HS; Yang Y; Lee S; Park S; Nam CM; Jee SH
    Int J Colorectal Dis; 2022 Aug; 37(8):1827-1834. PubMed ID: 35831458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: national cohort study.
    Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Urbonas V; Smailyte G
    Eur J Cancer Prev; 2020 Jul; 29(4):289-293. PubMed ID: 31567536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 Diabetes and Colorectal Cancer Risk.
    Lawler T; Walts ZL; Steinwandel M; Lipworth L; Murff HJ; Zheng W; Warren Andersen S
    JAMA Netw Open; 2023 Nov; 6(11):e2343333. PubMed ID: 37962884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study.
    Cardel M; Jensen SM; Pottegård A; Jørgensen TL; Hallas J
    Cancer Med; 2014 Oct; 3(5):1458-66. PubMed ID: 25091592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus.
    Bradley MC; Ferrara A; Achacoso N; Ehrlich SF; Quesenberry CP; Habel LA
    Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):525-530. PubMed ID: 29716927
    [No Abstract]   [Full Text] [Related]  

  • 14. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Metformin Associated with a Lower Prevalence of Polyps, Adenomas, and Colorectal Carcinoma in Patients with Diabetes Mellitus?
    Canha MI; Ramos G; Prata R; Lages Martins P; Viúla Ramos M; Coimbra J
    J Gastrointest Cancer; 2024 Mar; 55(1):435-443. PubMed ID: 37987968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.
    Sehdev A; Shih YC; Vekhter B; Bissonnette MB; Olopade OI; Polite BN
    Cancer; 2015 Apr; 121(7):1071-8. PubMed ID: 25424411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin use and survival after colorectal cancer: A population-based cohort study.
    Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
    Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and Colorectal Cancer - A Systematic Review.
    Kobiela J; Dobrzycka M; Jędrusik P; Kobiela P; Spychalski P; Śledziński Z; Zdrojewski T
    Exp Clin Endocrinol Diabetes; 2019 Jul; 127(7):445-454. PubMed ID: 29954001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus.
    Marks AR; Pietrofesa RA; Jensen CD; Zebrowski A; Corley DA; Doubeni CA
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1692-8. PubMed ID: 26377195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
    Kowall B; Stang A; Rathmann W; Kostev K
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.